Evaluation of Interferon Gamma Release Assay in the Diagnosis of Active and ‎Latent Tuberculosis among Patients and Contacts ‎

Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis

The predictive value of laboratory biomarkers in defining COVID-19 severity

Continuous medical education activities; Case No. 2: Exposure to suspected or confirmed COVID-19 case

Co-infection of covid-19 in two patients with active tuberculosis: first case report in Afghanistan

Antibody responses to acute COVID-19 infection; assessment via multiplex LABScreen COVID Plus Assay

Measles IgG Antibodies: Is There a Protective Role in COVID 19 Pandemic?‎ ‎

High SARS CoV2 antibody-prevalence among health care workers with variable exposure to COVID-19 patients: A cross-sectional university hospital study.

Is COVID-19 masking or delayed the diagnosis of active pulmonary tuberculosis? A case report from Bangladesh

Serum levels of tumor necrosis factor alpha and interferon alpha in COVID-19 patients and their correlations with disease severity.